Michael Leek PhD, MBA

Michael has 30 years’ experience in regenerative medicine, during which he progressed 9 different cell-based products from the laboratory into the clinic. As co-founder, he was jointly responsible for moving Intercytex from a pre-clinical research company to AIM-listed biotech with several cell therapy products in the clinic. He has extensive GMP manufacture, clinical, regulatory and logistic expertise, he has directly raised over $60m in equity and grant funding.